Antiandrogenic agents as monotherapy in advanced prostatic carcinoma-Reference-Cited by-同舟云学术

Antiandrogenic agents as monotherapy in advanced prostatic carcinoma

Published:1993-02-01 Issue:S3 Volume:71 Page:1083-1088
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Soloway Mark S.,Matzkin Haim

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference45 articles.

1. Carcinoma of the Prostate

2. Cancer Statistics, 1989

3. Urologic Aspects of Malformations and Common Abnormalities of the Anus and Rectum

4. , A complete androgen blockade for the treatment of prostate cancer. In: , , editors. Important advances in oncology. Philadelphia: JB Lippincott, 1985: 183–9.

5. Pharmacology of antiandrogens and valueof combining androgen suppression with antiandrogen therapy

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ten- and 15-yr Prostate Cancer-specific Mortality in Patients with Nonmetastatic Locally Advanced or Aggressive Intermediate Prostate Cancer, Randomized to Lifelong Endocrine Treatment Alone or Combined with Radiotherapy: Final Results of The Scandinavian Prostate Cancer Group-7;European Urology;2016-10

2. Serum Testosterone Level to Predict the Efficacy of Sequential Use of Antiandrogens as Second-line Treatment Following Androgen Deprivation Monotherapy in Patients with Castration-resistant Prostate Cancer;Japanese Journal of Clinical Oncology;2010-10-14

3. Growth inhibition of androgen-responsive prostate cancer cells with brefeldin A targeting cell cycle and androgen receptor;Journal of Biomedical Science;2010-01-26

4. The anti-androgen effect of ganoderol B isolated from the fruiting body of Ganoderma lucidum;Bioorganic & Medicinal Chemistry;2007-07

5. Androgen receptor signaling is required for androgen-sensitive human prostate cancer cell proliferation and survival;Cancer Cell International;2005